![]() |
|
|
Forward to a colleague |
||
Product Brochure Now you can perform early stage formulation development and clinical experiments starting at 15 gr./batch. Get all critical process parameters in real time and in Excel report. Modular design allows many upgrade possibilities... Click Here Access Full Stories Roche's latest takeover bid extension has been brushed off by histopathology diagnostics expert Ventana as it believes 'it is worth significantly more' than the current $3bn (€2.1bn) offer... Read Wyatt lights up protein aggregation Wyatt Technologies has launched a new instrument that automates protein aggregation measurement for use in all areas of the pharmaceutical industry from drug development to quality control (QC)... Read ProImmune launches T cell antigen prediction assay ProImmune has launched a new cell-free assay for Class II HLA (human leukocyte antigen) that can help understand key helper T cell immune responses and aid the design of highly targeted therapies... Read Industry news in brief - week 39 LabTechnologist.com brings you its periodic round up of industry news, with new developments at Agilent, Celera, Eppendorf, GATC Biotech, ThalesNano and Warwick Analytical Services... Read DSM takes on purification tech Netherlands-based DSM has invested an undisclosed sum in Danish purification technology company Upfront Chromatography to boost its protein separation business... Read |
||||||||||||||
All News Headlines for: September | August | July |
||||||||||||||
|
DOSE IT - For easy dispensing of media and buffers Finally a programmable peristaltic pump with easy on-screen instructions and self-explanatory operation! If you are tired of complex pump operation, watch the DOSE IT online video or download the product information on the INTEGRA Biosciences website... Click Here |
||||||||||||||
|
Related Industry News New UK joint venture bets on membrane biology services A UK university and a British consultancy firm have teamed up to offer outsourced R&D services focused on membrane biology - an increasingly promising area of drug development... Read Gardasil beware, Cervarix hot on your heels GlaxoSmithKline (GSK) has been granted EU approval of its adjuvanted cervical cancer vaccine Cervarix, and is confident that the jab can challenge the likes of Merck's high-profile Gardasil... Read Merck's HIV vaccine steps out of development Merck & Co. has stopped the Phase II trial of its V520 HIV vaccine after interim results showed that the vaccine was not effective and did not prevent infection... Read Sanofi imaging cancer drug 'sensors' Sanofi-Aventis is using the latest targeted imaging techniques to assess how its cancer drugs affect organisms at the molecular level... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||